GENeral practitioners and Embolism pRevention in NVAF patients treated with RivAroxaban : reaL life evidence
Not Applicable
- Conditions
- on-valvular atrial fibrillation
- Registration Number
- JPRN-UMIN000019135
- Lead Sponsor
- Japan Cardiovascular Research Foundation
- Brief Summary
Currently being analyzed
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 5732
Inclusion Criteria
Not provided
Exclusion Criteria
- Patients are contraindicated for rivaroxaban - Patients judged as inappropriate for this study by investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method